Novel Agents Promising in Pruritus, Rare Metabolic Disease, and More
(MedPage Today) -- Research on treatment for APOL1-mediated kidney disease and kidney troubles in COVID-19 patients, as well as DIAMOND trial data, were highlights at the 2022 National Kidney Foundation Spring Clinical Meetings. Below are a few...
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news
More News: COVID-19 | Urology & Nephrology